Early outcomes of group B streptococcal meningitis in the 21st century

Pediatric Infectious Disease Journal

Volumn 29, Issue 11, 2010, Pages 1009-1012

  Levent, Fatma ^a   Baker, Carol J ^a   Rench, Marcia A ^a   Edwards, Morven S ^a  

^a TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

Group B Streptococcus; meningitis; neonate; outcomes

Indexed keywords

AMPICILLIN; CEFOTAXIME; GENTAMICIN; PENICILLIN G; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; CEREBRAL BLINDNESS; CLONUS; COMA; CONTROLLED STUDY; DYSPHAGIA; FEMALE; GESTATION PERIOD; GROUP B STREPTOCOCCAL MENINGITIS; HEARING LOSS; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; INFANT; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MUSCLE HYPERTONIA; MUSCLE HYPOTONIA; NEUTROPENIA; PALLOR; PATIENT ASSESSMENT; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; PTOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SEIZURE; STREPTOCOCCUS AGALACTIAE; SURVIVOR; TREATMENT DURATION;

EID: 78149281740     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181e74c83     Document Type: Article

References (18)

1. Centers for Disease Control and Prevention. Active Bacterial Core Surveillance (ABCs) Report Emerging Infections Program Network Group B Streptococcus, 2008. Available at: http://www.cdc.gov/ncidod/dbmd/abcs/ survreports/gbs08.pdf. Accessed April 20, 2010.
2. Centers for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. Morb Mortal Wkly Rep. 2002;51:1-22.
3. Committee on Infectious Diseases and Committee on Fetus and Newborn. Guidelines for prevention of group B streptococcal (GBS) infection by chemoprophylaxis. Pediatrics. 1992;90:775-778.
4. Centers for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease: a public health perspective. Morb Mortal Wkly Rep. 1996;45:1-24.
5. Phares CR, Lynfield R, Farley MM, et al. Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA. 2008;299:2056-2065. (Pubitemid 351656587)
6. Baker CJ, Barrett FF, Gordon RC, et al. Suppurative meningitis due to streptococci of Lancefield group B: a study of 33 infants. J Pediatr. 1973;82:724-729.
7. Edwards MS, Rench MA, Haffar AA, et al. Long-term sequelae of group B streptococcal meningitis in infants. J Peditar. 1985;106:717-722.
8. Wald ER, Bergman I, Taylor HG, et al. Long-term outcome of group B streptococcal meningitis. Pediatrics. 1986;77:217-221.
9. Chin KC, Fitzhardinge PM. Sequelae of early-onset group B hemolytic streptococcal meningitis. J Pediatr. 1985;106:819-822.
10. Baker CJ, Webb BJ, Jackson CV, et al. Countercurrent immunoelectrophoresis in the evaluation of infants with group B streptococcal disease. Pediatrics. 1980;60:1110-1114.
11. Klinger G, Chin CN, Beyene J, et al. Predicting the outcome of neonatal bacterial meningitis. Pediatrics. 2000;106:477-482.
12. Lancefield RC. Serologic differentiation of specific types of bovine hemolytic streptococci. J Exp Med. 1934;59:441-458.
13. Centers for Disease Control and Prevention. Early-onset and late-onset neonatal group B streptococcal disease-United States, 1996-2004. Morb Mortal Wkly Rep. 2005;54:1205-1208.
14. Stoll BJ, Hansen NI, Adams-Chapman I, et al. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA. 2004;292:2357-2365.
15. Puopolo KM, Madoff LC, Eichenwald EC. Early-onset group B streptococcal disease in the era of maternal screening. Pediatrics. 2005;115:1240-1246.
16. Roine I, Peltola H, Fernández J, et al. Influence of admission findings on death and neurological outcome from childhood meningitis. Clin Infect Dis. 2008;46:1248-1252.
17. Adams-Chapman I, Stoll BJ. Neonatal infection and long-term neurodevelopmental outcome in the preterm infant. Curr Opin Infect Dis. 2006;19:290-297.
18. Stevens JP, Eames M, Kent A, et al. Long term outcome of neonatal meningitis. Arch Dis Child Fetal Neonatal Ed. 2003;88:F179-F184.